Achillion Pharmaceuticals Inc. | TalkMarkets | Page 1

Achillion Pharmaceuticals Inc. | TalkMarkets | Page 1

Sign Up
Sign up with:

People who follow this stock (2)

View All

Latest Articles

About This Stock More About This Stock

Achillion Pharmaceuticals Continues To Impress With Hepatitis C Results In A Combination Study

Article By: Terry Chrisomalis

Tuesday, November 11, 2014 10:55 AM EDT

ACH-3102 showed 100% Hepatitis C virus clearance in combination with Gilead's sofosbuvir.

In this article: ACHN, GILD

Twitter Top 10 Holds Up

Article By: Blair Jensen

Friday, October 3, 2014 3:18 PM EDT

The Twitter Top 10 portfolio held up reasonably well this month. It was only down a bit over 1% while the S&P 500 Index is down about 2%.

In this article: BAC, FDX, NKE, ACHN, LULU, MSFT, MU, TWTR, FEYE

Twitter Top 10 Down Slightly

Article By: Blair Jensen

Thursday, September 25, 2014 3:54 PM EDT

The Twitter Top 10 portfolio is slightly down this month and is performing similar to the S&P 500 Index. The only real leader this month is Bank of America up over 5%.

In this article: BAC, JCP, ACHN, NFLX, SPX

Twitter Top 10 Portfolio Turns Down

Article By: Blair Jensen

Friday, September 19, 2014 3:46 PM EDT

The Twitter Top 10 Portfolio is taking a turn lower this month. The portfolio is being hurt by JC Penney (JCP) down 8%, Achillion Pharmaceuticals (ACHN) down 5%, and Netflix (NFLX) down 4%.

In this article: BAC, JCP, ACHN, BIDU, NFLX, FB, TWTR

New Picks For Twitter Top 10 Portfolio

Article By: Blair Jensen

Friday, September 5, 2014 5:41 PM EDT

Over the past month the Twitter Top 10 portfolio basically tracked the market. There were two big gainers Twitter (TWTR) and Gilead Sciences (GILD). Both were up around 14%. The big drag on the portfolio was El Pollo Loco (LOCO) down nearly 14%.

In this article: BAC, JCP, ACHN, BIDU, GILD, NFLX, FB, TWTR, GOOGL

Roche Wastes No Time, Acquires Intermune For $8.3 Billion Dollars

Article By: Terry Chrisomalis

Tuesday, August 26, 2014 4:19 PM EDT

Roche deal spurs merger and acquisition activity across the biotech industry.

In this article: RHHBY, ACHN, ITMN, ARWR, RXII